Literature DB >> 28531906

Tocilizumab-Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in Adult-Onset Still Disease.

Elina Zuelgaray1, Fanny Domont1, Nathan Peiffer-Smadja1, David Saadoun1, Patrice Cacoub1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28531906     DOI： 10.7326/L16-0592

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  3 in total

Review 1.  Immunogenicity of biologic agents in rheumatology.

Authors:  Vibeke Strand; Joao Goncalves; John D Isaacs
Journal:  Nat Rev Rheumatol       Date:  2020-12-14       Impact factor: 20.543

2.  'Toxic erythema' and eosinophilia associated with tocilizumab therapy in a COVID-19 patient.

Authors:  A Sernicola; G Carnicelli; M Di Fraia; C Chello; C Furlan; R Muharremi; G Paolino; T Grieco
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-08       Impact factor: 9.228

3.  Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper.

Authors:  Aslı Gelincik; Knut Brockow; Gülfem E Çelik; Inmaculada Doña; Cristobalina Mayorga; Antonino Romano; Özge Soyer; Marina Atanaskovic-Markovic; Annick Barbaud; Maria Jose Torres
Journal:  Allergy       Date:  2020-07-01       Impact factor: 14.710
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.